Atlas Trials

To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.

Clinical trial NCT05196295 · UNKNOWN

Trial details

NCT number
NCT05196295
Sponsor
HoHo Biotech
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune DiseasesMetabolic Disease
Start date
2022-01-11
Primary completion
2022-07-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.